These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9537437

  • 21. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 22. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 23. Hepatocellular carcinoma: role of estrogen receptors in the liver.
    Villa E, Grottola A, Colantoni A, De Maria N, Buttafoco P, Ferretti I, Manenti F.
    Ann N Y Acad Sci; 2002 Jun; 963():37-45. PubMed ID: 12095926
    [Abstract] [Full Text] [Related]

  • 24. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, Akuta N, Someya T, Hosaka T, Sezaki H, Kobayashi M, Kumada H.
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [Abstract] [Full Text] [Related]

  • 26. Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers.
    Ucur A, Palanduz S, Cefle K, Ozturk S, Tutkan G, Vatansever S, Erden S, Karan MA, Erten N, Guler K, Tascioglu C.
    Hepatogastroenterology; 2003 Jan; 50(54):2137-40. PubMed ID: 14696481
    [Abstract] [Full Text] [Related]

  • 27. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 28. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.
    Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ.
    Hepatology; 2003 Dec; 38(6):1393-400. PubMed ID: 14647050
    [Abstract] [Full Text] [Related]

  • 29. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A, Soresi M, Bonfissuto G, Magliarisi C, Anastasi G, Vuturo O, Notarbartolo A, Montalto G.
    Ann Ital Med Int; 1999 Dec; 14(4):233-8. PubMed ID: 10638015
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 32. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M, Mikuni M, Matsumura H, Nakamura H, Oshiro S, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Tanaka N, Arakawa Y.
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [Abstract] [Full Text] [Related]

  • 33. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen.
    Tsay PK, Tai DI, Chen YM, Yu CP, Wan SY, Shen YJ, Lin DY.
    Chang Gung Med J; 2009 Apr; 32(2):155-64. PubMed ID: 19403005
    [Abstract] [Full Text] [Related]

  • 34. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 35. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H.
    J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
    [Abstract] [Full Text] [Related]

  • 36. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF, Jeng LB, Lee WC, Chen TC.
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.
    J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774
    [Abstract] [Full Text] [Related]

  • 38. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H.
    J Viral Hepat; 2009 Jun 15; 16(6):437-43. PubMed ID: 19226331
    [Abstract] [Full Text] [Related]

  • 39. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 15; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.